North America Sleep Apnea Devices Market is Expected to Reach $13.5 Billion by 2019

FORT WORTH, Texas (Feb. 18, 201)—The sleep apnea devices market is marked by a high degree of competition. There are a few well-established firms and several small firms that operate in this industry. Agreements, mergers and acquisitions, partnerships, and collaborations form an important strategy to enhance the bottom line of the key players in this market. 17 percent of the companies channelize their efforts in coalitions, including M&As.The North American sleep apnea devices market is  estimated to grow at a CAGR of 15.9 percent. The therapeutic sleep apnea devices market constitutes the largest segment of this market, registering around 55.6 percent.

The report “North American Sleep Apnea Devices Market forecast, 2012-2019” analyzes the market of devices by two segments—diagnostic & therapeutic sleep apnea devices. These segments experience a substantial positive growth owing to the increased awareness among the care givers and patients. Positive Airway Pressure devices segment has been contributing largely towards the total North American Therapeutic Sleep Apnea devices industry. 

U.S. accounted for the largest market share in 2012, followed by Canada. This is chiefly attributed to the increasing healthcare awareness regarding sleep apnea, rising disposable income, improved healthcare infrastructure, high insurance coverage and better reimbursement scenario, besides, the rising cases of obesity adding to the pool of sleep apnea patients.

Center for Medicare & Medicaid Services (CMS) provides coverage for several sleep apnea products, including a capped rental on CPAP/BiPAP equipment, oral appliances, and other supplies. According to National Sleep Foundation, in 2012, around 40 million Americans were reported to suffer from chronic sleep disorder.  Furthermore, as per centers for Disease Control and Prevention (CDC), 36 percent of the U.S. adults were obese in 2010, and nearly 42% percent will be obese by the year 2030.

In Canada, the Canadian Trucking Alliance (CTA), in partnership with OSA Canada, Inc., launched sleep apnea screening and treatment pilot program to counter the challenges of sleep apnea in the trucking industry.

The report  provides a detailed competitive landscape of companies operating in this market. Segment and country specific company shares, news & deals, M&A, segment specific pipeline products, product approvals and product recalls of the major companies have been detailed. The main companies operating in this market are Philips Respironics, a subsidiary of Philips Healthcare (The Netherlands); ResMed (U.S.), Compumedics Limited (Australia), CarefusionCorporation (U.S.), Curative Medical, Inc. (U.S.), BMC Medical Co., Ltd. (China), Natus Medical Incorporated (U.S.), Fisher and Paykel Healthcare, Ltd. (New Zealand), DeVilbiss Healthcare (U.S.), Global Medical Holdings, LLC (U.S.), Itamar Medical, Ltd. (U.S.), and Weinmann Medical Devices GmbH & Co. KG (Germany).